XML 34 R20.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Parent Company Financial Statements (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2021
Parent Company Financial Statements (Unaudited) |
Parent Company Financial Statements (Unaudited) | 15. Parent Company Financial Statements (Unaudited) We conduct substantially all of our operations through subsidiaries and are dependent on cash distributions, dividends and other intercompany transfers of funds from our operations. Our subsidiaries have not made significant distributions to us and may not have funds available for dividends or distributions in the future. The ability of our subsidiaries to transfer funds to us will be dependent upon their respective abilities to achieve sufficient cash flows after satisfying their respective cash requirements, including subsidiary level debt service on their respective credit agreements. The following is a summary of the Parent Company Financial statements. Aemetis, Inc. (Parent Company) Balance Sheets As of December 31, 2021 and 2020
Assets |  | 2021 |  |  | 2020 |
Current assets |  |  |  |  |  |
Cash and cash equivalents |  | $ | - |  |  | $ | 318 |
Receivables due from subsidiaries |  |  | 93,571 |  |  |  | - |
Prepaid expenses |  |  | 290 |  |  |  | 252 |
Other current assets |  |  | 116 |  |  |  | - |
Total current assets |  |  | 93,977 |  |  |  | 570 |
Investment in AE Advanced Products Keyes , Inc. |  |  | - |  |  |  | 12 |
Investment in Aemetis Property Keyes, Inc. |  |  | 496 |  |  |  | - |
Investment in Aemetis International, Inc. |  |  | 2,546 |  |  |  | 4,196 |
Investment in Aemetis Advanced Products Riverbank, Inc. |  |  | 23 |  |  |  | - |
Investment in Aemetis Carbon Capture, Inc. |  |  | 54 |  |  |  | - |
Total investments in Subsidiaries, net of advances |  |  | 3,119 |  |  |  | 4,208 |
Property, plant and equipment, net |  |  | 36 |  |  |  | 9 |
Other assets |  |  | 2,475 |  |  |  | 2,700 |
Total Assets |  | $ | 99,607 |  |  | $ | 7,487 |
Liabilities & stockholders' deficit |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 3,024 |  |  | $ | 4,881 |
Payables due to subsidiaries |  |  | - |  |  |  | 4,390 |
Mandatorily redeemable Series B convertible preferred |  |  | 3,806 |  |  |  | 3,252 |
Other current liabilities |  |  | 9,521 |  |  |  | 11,930 |
Total current liabilities |  |  | 16,351 |  |  |  | 24,453 |
Long term liabilities: |  |  |  |  |  |  |  |
Other long term debt |  |  | - |  |  |  | 150 |
Operating lease liability |  |  | 2,318 |  |  |  | - |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 150,424 |  |  |  | 131,432 |
Investment in Aemetis Americas, Inc |  |  | 205 |  |  |  | 205 |
Investment in Aemetis Biofuels, Inc. |  |  | 2,738 |  |  |  | 2,738 |
Investment in Aemetis Technologies, Inc. |  |  | 4,536 |  |  |  | 4,446 |
Investment in Aemetis Property Keyes, Inc. |  |  | - |  |  |  | 247 |
Investment in AE Advanced Products Keyes , Inc. |  |  | 383 |  |  |  | - |
Investment in Aemetis Health Products, Inc. |  |  | 2,137 |  |  |  | 441 |
Investment in Goodland Advanced Fuels, Inc. |  |  | 13,587 |  |  |  | 12,201 |
Investment in Aemetis Biogas LLC |  |  | 27,166 |  |  |  | 15,918 |
Total subsidiary obligation in excess of investment |  |  | 201,176 |  |  |  | 167,628 |
Total long term liabilities |  |  | 203,494 |  |  |  | 167,778 |
Stockholders' deficit |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | 1 |  |  |  | 1 |
Common stock |  |  | 33 |  |  |  | 23 |
Additional paid-in capital |  |  | 205,305 |  |  |  | 93,426 |
Accumulated deficit |  |  | (321,227 | ) |  |  | (274,080 | )
Accumulated other comprehensive loss |  |  | (4,350 | ) |  |  | (4,114 | )
Total stockholders' deficit |  |  | (120,238 | ) |  |  | (184,744 | )
Total liabilities & stockholders' deficit |  | $ | 99,607 |  |  | $ | 7,487 |
Aemetis, Inc. (Parent Company) Statements of Operations and Comprehensive Loss For the Years Ended December 31, 2021, 2020, and 2019
|  | 2021 |  |  | 2020 |  |  | 2019 |
Equity in subsidiary losses |  | $ | (34,400 | ) |  | $ | (28,820 | ) |  | $ | (21,745 | )
Selling, general and administrative expenses |  |  | 11,806 |  |  |  | 6,707 |  |  |  | 6,673 |
Operating loss |  |  | (46,206 | ) |  |  | (35,527 | ) |  |  | (28,418 | )
Other (income) expense |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | 1,031 |  |  |  | 677 |  |  |  | 1,392 |
Other (income) expense |  |  | (97 | ) |  |  | 448 |  |  |  | 5,899 |
Loss before income taxes |  |  | (47,140 | ) |  |  | (36,652 | ) |  |  | (35,709 | )
Income tax expense |  |  | 7 |  |  |  | 7 |  |  |  | 7 |
Net loss |  |  | (47,147 | ) |  |  | (36,659 | ) |  |  | (35,716 | )
Other comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | (27 | ) |  |  | (289 | ) |  |  | (249 | )
Comprehensive loss |  | $ | (47,174 | ) |  | $ | (36,948 | ) |  | $ | (35,965 | )
Aemetis, Inc. (Parent Company) Statements of Cash Flows For the years ended December 31, 2021, 2020, and 2019
|  | 2021 |  |  | 2020 |  |  | 2019 |
Operating activities: |  |  |  |  |  |  |  |  |
Net loss |  |  | (47,147 | ) |  |  | (36,659 | ) |  |  | (35,716 | )
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 3,928 |  |  |  | 995 |  |  |  | 774 |
SARs Amortization |  |  | - |  |  |  | - |  |  |  | 800 |
Depreciation |  |  | 8 |  |  |  | 4 |  |  |  | 8 |
Subsidiary portion of net losses |  |  | 34,400 |  |  |  | 28,820 |  |  |  | 21,745 |
Change in fair value of SARs liability |  |  | - |  |  |  | - |  |  |  | (82 | )
Gain on debt extinguishment |  |  | (421 | ) |  |  | - |  |  |  | - |
Changes in assets and liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Prepaid expenses |  |  | (38 | ) |  |  | 38 |  |  |  | 74 |
Accounts payable |  |  | (1,043 | ) |  |  | (216 | ) |  |  | 71 |
Accrued interest expense |  |  | 998 |  |  |  | 525 |  |  |  | 1,184 |
Other liabilities |  |  | (902 | ) |  |  | (578 | ) |  |  | 5,891 |
Other assets |  |  | 109 |  |  |  | 236 |  |  |  | (232 | )
Net cash used in operating activities |  |  | (10,108 | ) |  |  | (6,835 | ) |  |  | (5,483 | )
Investing activities: |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary advances, net |  |  | (95,105 | ) |  |  | 1,332 |  |  |  | 6,781 |
Net cash provided by (used in) investing activities |  |  | (95,105 | ) |  |  | 1,332 |  |  |  | 6,781 |
Financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from borrowings under secured debt facilities |  |  | - |  |  |  | 421 |  |  |  | - |
Repayments of borrowings under secured debt facilities |  |  | - |  |  |  | - |  |  |  | (1,298 | )
Proceeds from the exercise of stock options |  |  | 1,304 |  |  |  | 287 |  |  |  | - |
Proceeds from issuance of common stock in equity offering |  |  | 103,591 |  |  |  | 5,113 |  |  |  | - |
Net cash provided by (used in) financing activities |  |  | 104,895 |  |  |  | 5,821 |  |  |  | (1,298 | )
Net increase in cash and cash equivalents |  |  | (318 | ) |  |  | 318 |  |  |  | - |
Cash and cash equivalents at beginning of period |  |  | 318 |  |  |  | - |  |  |  | - |
Cash and cash equivalents at end of period |  | $ | - |  |  | $ | 318 |  |  | $ | - |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |  |  |  |  |
Interest payments |  | $ | - |  |  | $ | - |  |  | $ | - |
Income taxes paid |  |  | 7 |  |  |  | 7 |  |  |  | 8 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants issued to subordinated debt holders |  |  | 1,546 |  |  |  | 181 |  |  |  | 162 |
Fair value of warrants issued for capital expenditures |  |  | 1,344 |  |  |  | - |  |  |  | - |
Exercise of Stock Appreciation Rights added to GAFI debt |  |  | - |  |  |  | - |  |  |  | 1,050 |
Reclassification of GAFI Non-controlling interest |  |  | - |  |  |  | - |  |  |  | 8,501 |
Operating lease liabilities arising from obtaining right of use assets |  |  | - |  |  |  | 2,632 |  |  |  | 640 |
Issuance of equity to pay off accounts payable |  |  | 893 |  |  |  | - |  |  |  | - |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section S99 -Paragraph 6 -Subparagraph (SX 210.5-04(Schedule I)) -URI http://asc.fasb.org/extlink&oid=120391182&loc=d3e5864-122674 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration